Member Exclusive News

The week in industry: First cell-based flu vaccine now available in Europe

This week: EMA publishes a revised version of its guidelines for worldwide development of new antibiotics, clinical trial for HIV prevention treatment exceeds expectations and now hopes to increase the number of participants, and the EMA publishes draft guidance on antibiotic development.

Please sign in or register for FREE

No comments yet.